Tuberculosis treatment in complex emergencies: are risks outweighing benefits?
Abstract
Tuberculosis (TB) is a major public health problem in complex emergencies. Humanitarian agencies usually postpone the decision to offer TB treatment and opportunities to treat TB patients are often missed. This paper looks at the problem of tuberculosis treatment in these emergencies and questions whether treatment guidelines could be more flexible than international recommendations. A mathematical model is used to calculate the risks and benefits of different treatment scenarios with increasing default rates. Model outcomes are compared to a situation without treatment. An economic analysis further discusses the findings in a trade-off between the extra costs of treating relapses and failures and the savings in future treatment costs. In complex emergencies, if a TB programme could offer 4-month treatment for 75% of its patients, it could still be considered beneficial in terms of public health. In addition, the proportion of patients following at least 4 months of treatment can be used as an indicator to help evaluate the public health harm and benefit of the TB programme.PubMed ID
12631310Language
enISSN
1360-2276Collections
Related articles
- Tuberculosis in complex emergencies.
- Authors: Coninx R
- Issue date: 2007 Aug
- Control of tuberculosis by community health workers in Bangladesh.
- Authors: Chowdhury AM, Chowdhury S, Islam MN, Islam A, Vaughan JP
- Issue date: 1997 Jul 19
- Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti.
- Authors: Jacquet V, Morose W, Schwartzman K, Oxlade O, Barr G, Grimard F, Menzies D
- Issue date: 2006 Aug 15
- How much does tuberculosis cost? An Australian healthcare perspective analysis.
- Authors: Chan E, Nolan A, Denholm J
- Issue date: 2017 Sep 1
- DOTS in Cambodia. Directly observed treatment with short-course chemotherapy.
- Authors: Norval PY, San KK, Bakhim T, Rith DN, Ahn DI, Blanc L
- Issue date: 1998 Jan